期刊文献+

基质金属蛋白酶-1、9和金属蛋白酶组织抑制因子-1对心房结构重构的作用 被引量:5

Role of matrix metalloproteinases 1 and 9 and tissue inhibitor of metalloproteinase 1 in atrial structural remodeling
下载PDF
导出
摘要 目的检测基质金属蛋白酶(MMP)-1、9和金属蛋白酶组织抑制因子(TIMP)-1在风湿性心脏病(风心病)心房颤动(房颤)患者左心房中的表达,探讨其在心房结构重构中的作用。方法选择接受外科换瓣手术的风心病患者43例,其中窦性心律(RSR)组15例,阵发房颤(PAF)组8例,慢性房颤(CAF)组20例。在外科手术中取左心房组织,分别应用免疫印迹法和逆转录-聚合酶链反应测定MMP-1、9和TIMP-1的蛋白含量和mRNA表达量。结果①与RSR组比较,CAF组MMP-9的蛋白水平和mRNA表达均明显增加(P值均<0.01),TIMP-1蛋白水平和mRNA表达均明显降低(P值均<0.01)。各组间MMP-1蛋白水平和mRNA表达的差异均无统计学意义(P值均<0.05)。②CAF组中,MMP-9蛋白水平、mRNA表达与左心房内径(r=0.512、0.500)、房颤持续时间(r=0.927、0.950)均呈正相关(P值均<0.01);TIMP-1则与左心房内径(r=-0.695、-0.401)、房颤持续时间(r=-0.672、-0.695)均呈负相关(P值均<0.01)。TIMP-1与MMP-9蛋白水平和mRNA表达均呈负相关(r值分别=-0.811、-0.655,P值均<<0.01)。结论风心病合并慢性房颤患者的左心房组织中,MMP-9蛋白水平和基因表达均增强,TIMP-1蛋白水平和基因表达则减弱;MMP-9/TIMP-1平衡失调促进心房结构和功能的改变,参与房颤发生和维持。 Objective To detect the expressions of matrix metalloproteinases 1 and 9(MMP-1 and MMP-9) and tissue inhibitor of MMP-1(TIMP-1) in the left atrium of patients with rheumatic heart disease(RHD) complicated with atrial fibrillation(AF), and to investigate their role in atrial structural remodeling. Methods Forty-three RHD patients undergoing valve replacement were enrolled in this study, including 15 patients with regular sinus rhythm(RSR group), 8 with paroxysmal AF(PAF group) and 20 with chronic AF(CAF group). The atrial samples were obtained during surgery for Western blotting to detect the MMP-1, MMP-9 and TIMP-1 protein expressions, and their mRNA expression was detected using reverse transcriptional polymerase chain reaction(RTPCR). Results Compared with RSR group, patients with CAF showed increased MMP-9 mRNA and protein expression(P〈 0.01) and decreased TIMP-1 mRNA and protein expression in the atrium(P 〈 0. 01), but such changes were not observed in patients with PAF. The expression of MMP-1 at both the mRNA and protein levels showed no significant differences between the 3 groups. In CAF patients, MMP-9 mRNA and protein expressions in the left atrium was positively, but TIMP-1 expression was inversely correlated with the left atrium dimension and AF du ration(P 〈 0.01), and a significant inverse correlation was indicated between MMP-9 and TIMP-1 expression at both the mRNA and protein levels. Conclusions MMP-9 expression is upregulated and TIMP-1 is downregulatcd in the left atrium of the RHD patients with AF. Disturbed balance between MMP-9 and TIMP-1 may promote the structural and functional changes of the atria and is associated with the occurrence and persistence of AF.
出处 《上海医学》 CAS CSCD 北大核心 2008年第1期55-58,共4页 Shanghai Medical Journal
关键词 心房颤动 基质金属蛋白酶 金属蛋白酶组织抑制因子 心房重构 Atrial fibrillation Matrix metalloproteinases Tissue inhibitor of metalloproteinase Atrial remodeling of structure
  • 相关文献

参考文献8

  • 1Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res, 2002, 54:230-246.
  • 2柯丹,许春萱,张建成,陈林,林亚洲,林立芳,胡锡衷.心房颤动患者心房组织中明胶酶的基因表达及活性变化[J].中华心血管病杂志,2005,33(2):137-142. 被引量:26
  • 3Kleiner D E, Stetler-Stevenson W G. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 1999, 43 (Suppl) : S42-S51.
  • 4Nakano Y, Niida S, Dote K, et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coil Cardiol, 2004, 43:818-825.
  • 5Xu J, Cui G, Esmailian F,et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation, 2004,109 : 363-368.
  • 6Nishikawa N, Yamamoto K, Sakata Y, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventrieular dilatation. Cardiovase Res, 2003, 57:766-774.
  • 7Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med, 1999, 5:1135-1142.
  • 8Rouet-Benzineb P, Buhler J M, Dreyfus P, et al. Altered balance between matrix gelatinases (MMP-2 and MMP-9 ) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Eur J Heart Fail, 1999, 1,337-352.

二级参考文献14

  • 1Thomas H, Li H, Mangrum M, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation . Circulation, 2000, 102: 1454-1460.
  • 2Xu J, Cui G, Esmailian F, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation, 2004 , 109:363-368.
  • 3Reinhardt D, Sigusch H, Henbe J, et al. Cardiac remodelling in end stage heart failure:upregulation of matrix metalloproteinase(MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart, 2002,88:525-530.
  • 4Ausma J, Van der Velden HM, Lenders MH, et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation,2003,107:2051-2058.
  • 5Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 1997 , 96:1180 -1184.
  • 6Brilla CG.Renin-angiotensin-aldosterone system and myocardial fibrosis. Cardiovasc Res, 2000,47:1-3.
  • 7Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol, 2000,35:1669 -1677.
  • 8Nagase H. Activation mechanisms of matrix metalloproteinase. Biol Chem, 1997,378:151-160.
  • 9Rouet-Benzineb P, Gontero B, Dreyfus P, et al. Angiotensin II indrces nuclear factor-kappa-B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Cell Cardiol, 2000,32:1767-1778.
  • 10Tyagi SC, Lewis K, Pikes D, et al. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J Cell Physiol, 1998,176:374-382.

共引文献25

同被引文献96

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部